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Abstract
 
Hepatocyte apoptosis is crucial in several forms of liver disease. Here, we examined in different
models of murine liver injury whether and how metabolically induced alterations of hepatocyte
ATP levels control receptor-mediated apoptosis. ATP was depleted either in primary hepato-
cytes or in vivo by various phosphate-trapping carbohydrates such as fructose. After the activa-
tion of the tumor necrosis factor (TNF) receptor or CD95, the extent of hepatocyte apoptosis
 
and liver damage was quantified. TNF-induced cell death was completely blocked in ATP-
depleted hepatocyte cultures, whereas apoptosis mediated by CD95 was enhanced. Similarly
 
,
 
acute TNF-induced liver injury in mice was entirely inhibited by ATP depletion with keto-
hexoses, whereas CD95-mediated hepatotoxicity was enhanced. ATP depletion prevented mi-
tochondrial cytochrome c release, loss of mitochondrial membrane potential, activation of type
II caspases, DNA fragmentation, and cell lysis after exposure to TNF. The extent of apoptosis
inhibition correlated with the severity of ATP depletion, and TNF-induced apoptosis was re-
stored when ATP was repleted by increasing the extracellular phosphate concentration. Our
study demonstrates that TNF-induced hepatic apoptosis can be selectively and reversibly
blocked upstream of mitochondrial dysfunction by ketohexose-mediated ATP depletion.
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Introduction
 
While a low frequency of apoptosis ensures homeostasis
and functional adaptation of liver size (1), increased rates of
hepatocyte apoptosis are observed in a plethora of patho-
logical situations. These include ischemia, transplant rejec-
tion, intoxications, viral infections, and autoimmune dis-
eases (1–3). Frequently, release of cytokines (3) and death
receptor activation are involved in such apoptotic hepato-
cyte death (2). Data from experimental models of liver fail-
ure suggest that distinct sets of cytokines trigger apoptosis
in different types of liver disease. The two best character-
ized death pathways are those triggered via the 55-kD TNF
receptor (TNF-R1) (4) or CD95 (5, 6). Apoptotic demise
triggered through either of these receptors shares some
common elements in hepatocytes, such as signal transduc-
tion via caspases, i.e., unique cysteine proteases involved in
the signaling of death receptors and the execution of apop-
tosis (7). Accordingly, inhibition of caspases prevents in
vivo and in vitro hepatocyte apoptosis signaled via either
receptor (8, 9). However, death triggered by either CD95
or TNF-R1 also shows some strikingly different features:
TNF-induced apoptosis requires sensitization of hepato-
cytes, e.g., by transcriptional inhibitors (10–12), and is fa-
cilitated by high oxygen tension (5), whereas CD95 signal-
ing has no such metabolic prerequisites (5). Conversely,
 
a
 
1-antitrypsin prevents TNF-mediated liver apoptosis but
has no effect on CD95-triggered hepatotoxicity (13). Con-
sequently, the different apoptotic pathways in the liver may
be targeted selectively.
For many therapeutic applications, selective inhibition of
apoptosis in the liver only is desirable. A way to achieve
such organ specificity is to exploit the metabolic peculiari-
ties of hepatocytes. For instance, depletion of hepatic glu-
tathione prevents CD95- and TNF-R1–mediated liver
failure (14, 15). The cellular ATP content is another apop-
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tosis-related metabolic parameter (16, 17) that may be
modified selectively in the liver. ATP depletion affects ap-
optotic pathways in three fundamentally different ways.
First, biochemical evidence suggests that ATP, together
with cytochrome c, is needed for the formation of the apop-
tosome (18), a protein complex involved in the processing
of procaspases (19). Accordingly, cellular ATP depletion
frequently prevents activation of execution caspases at a
step downstream of cytochrome c release (20, 21). Such
cells with damaged mitochondria are in most cases still des-
tined to die, but the absence of caspase activity switches the
mode of death from apoptosis to delayed necrosis (20–22).
Second, in some models, ATP depletion may block apop-
totic steps upstream of cytochrome c release from mito-
chondria (21, 22). In such cases, both caspase activation and
mitochondrial damage are prevented, and cells may truly
survive an otherwise lethal insult (23). Finally, in cases
where CD95 stimulation triggers a cascade of proteolytic
events that directly lead to apoptosome-independent acti-
vation of effector caspases, ATP depletion may have no ef-
fect at all on caspase activation (24) or cell death (25).
It is still unknown which of these roles ATP has in hepa-
tocyte apoptosis. An even more important open issue is the
function of ATP for apoptosis in well-defined in vivo
models of apoptotic organ failure. Such experiments in live
animals require metabolic inhibition, which is selective for
defined cell populations and thus excludes general inhibitors
of oxidative phosphorylation or glycolysis. A well-estab-
lished method for selective ATP depletion of hepatocytes,
in vivo and in vitro, is exposure to high concentrations of
fructose or other sugars that rapidly trap intracellular phos-
phate (26, 27). This approach has the advantage of ensuring
residual ATP levels (
 
.
 
15% of control) in the depleted
hepatocytes that are high enough to avoid induction of ne-
crosis (28, 29), which would result from more excessive
ATP loss (29–34).
In this study, we examined whether ATP depletion with
phosphate-trapping sugars could be used to elucidate the
role of ATP in liver cell death. Such an experimental sys-
tem may open new perspectives on the mechanisms of
pathological cell death and offer possibilities for selective
therapeutic interventions. Therefore, we examined differ-
ential effects of phosphate-trapping sugars on TNF- and
CD95-triggered apoptotic pathways in hepatocyte or
hepatoma cell cultures, and in models of liver damage in
mice.
 
Materials and Methods
 
Materials.
 
Recombinant murine TNF was provided by Dr.
G.R. Adolf, Bender GmbH (Vienna, Austria). 
 
d
 
-galactosamine
(GalN)
 
1
 
 was obtained from Roth Chemicals. Agonistic anti-
 
CD95 antibody (
 
a
 
CD95, clone Jo-2) was purchased from BD
PharMingen. All enzymes, the DNA fragmentation ELISA, and
the ATP test kit were obtained from Boehringer. The caspase
inhibitor benzoyloxycarbonyl-val-ala-asp-fluoromethylketone
(zVADfmk) was purchased from Bachem. Unless further speci-
fied, all other reagents were purchased from Sigma-Aldrich. Cell
culture plates were from Greiner. Culture medium was pur-
chased from BioWhittaker, and collagen was obtained from
Serva.
 
Animals.
 
Specific pathogen-free male BALB/c mice (25 g)
were from the in house Animal Breeding Facility of the Univer-
sity of Konstanz. Animals were held at 22
 
8
 
C and 55% humidity,
and given a constant day–night cycle of 12 h. Mice were starved
overnight before the in vivo experiments started. Experiments
generally commenced at 8 AM. All steps of animal handling were
performed according to the Guidelines of the European Council
(directive 86/609/EEC) and the national German authorities and
followed the directives of the University of Konstanz Ethical
Committee.
 
Cell Culture Experiments.
 
Hepatocytes were isolated from
8-wk-old mice by the two step collagenase perfusion method of
Seglen (35) and cultured as described (11). In brief, hepatocytes
were plated in 200 
 
m
 
l RPMI 1640 medium containing 10% FCS
in collagen-coated 24-well plates at a density of 8 
 
3
 
 10
 
4
 
 hepato-
cytes per well, or in collagen-coated 6-well plates at a density of
3.2 
 
3
 
 10
 
5
 
 hepatocytes per well. Cells were allowed to adhere to
culture dishes for 5 h before the medium was exchanged to
RPMI 1640 without FCS. HepG2 cells were maintained in
RPMI 1640 medium containing 10% FCS in 75-cm
 
2
 
 flasks. The
day before experiments were carried out, hepatoma cells were
harvested with trypsin/EDTA and plated in 200 
 
m
 
l RPMI 1640
medium containing 10% FCS in 24-well plates (10
 
5
 
 cells/well).
Incubation of murine hepatocytes or HepG2 cells with carbohy-
drates or inhibitors of protein synthesis was started directly after
medium exchange for RPMI 1640 without FCS. 30 min later,
hepatocyte apoptosis was induced by addition of either 
 
a
 
CD95
(0.37–300 ng/ml) alone or recombinant murine TNF (100 ng/
ml) after sensitization with actinomycin D (ActD, 400 ng/ml, 15
min before TNF). Incubations were carried out at 37
 
8
 
C in an at-
mosphere composed of 5% CO
 
2
 
, 40% O
 
2
 
, and 55% N
 
2
 
 for the
times indicated. Cytotoxicity was quantitated by measurement of
lactate dehydrogenase (LDH) (36) in culture supernatants (S) and
in the remaining cell monolayer (C) after lysis with 0.1% Triton
X-100, and calculation of the percentage of LDH release from
the ratio of S/(S 
 
1 
 
C). Specific cytotoxicity after incubation with
TNF and sugar was defined as: specific cytotoxicity (%)
 
 
 
5 
 
100% 
 
3
 
(LDH
 
TNF
 
1
 
sugar
 
 2 
 
LDH
 
basal
 
)/(LDH
 
TNF
 
 
 
2 
 
LDH
 
basal
 
).
 
In Vivo Experiments.
 
a
 
CD95 (2 
 
m
 
g/mouse) or TNF (2 
 
m
 
g/
kg) was injected intravenously in a volume of 300 
 
m
 
l saline (con-
taining 0.1% HSA). Mice were sensitized to TNF by intraperito-
neal injection of GalN (700 mg/kg) 15 min before the cytokine.
30 min before TNF or anti-CD95, fructose or tagatose were in-
jected at various doses (0.08–10 g/kg) in 300 
 
m
 
l pyrogen-free
water. Blood and tissue samples were obtained after lethal intra-
venous anesthesia of mice with 150 mg/kg pentobarbital plus 0.8
mg/kg heparin. After midline laparotomy and opening of the
chest, blood was withdrawn by cardiac puncture and immediately
centrifuged for 2 min at 4
 
8
 
C at 13,000 
 
g
 
 to separate the plasma
from the cellular fraction. Livers were perfused for 10 s with cold
perfusion buffer (PB: 50 mM phosphate, 120 mM NaCl, 10 mM
EDTA, pH 7.4), and subsequently excised (3). A slice of the large
anterior lobe was immediately fixated in 4% buffered formalin so-
lution for histological studies. A part of the liver was frozen in
 
1
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liquid nitrogen and stored at 
 
2
 
80
 
8
 
C for the determination of
caspase-3–like activity. The remaining parts of the liver were dis-
integrated with three strokes of an Elvehjem–type homogenizer.
The 20% homogenate (in PB) was centrifuged at 13,000 
 
g
 
 for 20
min. The supernatant was diluted 270-fold and used directly in an
ELISA designed to detect DNA fragmentation (11).
 
Metabolites.
 
ATP content of cultured hepatocytes or liver tis-
sue was determined luminometrically using a commercially avail-
able kit. In brief, hepatocytes (8 
 
3
 
 10
 
4
 
/well, 24-well plates) were
incubated with different stimuli and various carbohydrates. At the
desired time points, hepatocytes were lysed in 150 
 
m
 
l buffer
(Boehringer), immediately frozen at 
 
2
 
80
 
8
 
C, and stored until
measurement. Before the assay, frozen samples were thawed on
ice and diluted 20-fold. In animal experiments, livers were per-
fused for 2 s and immediately homogenized. The 10% homoge-
nate (in lysis buffer) was centrifuged at 13,000 
 
g
 
 for 5 min at 4
 
8
 
C.
The supernatants were frozen in liquid nitrogen and stored at
 
2
 
80
 
8
 
C. Luminescence was measured in 96-well plates using an
automated procedure (VICTOR
 
2
 
 multilabel counter; Wallac In-
struments). Data were compared with calibration solutions, and
ATP data are expressed as the percentage of untreated control
cells per liver. Glutathione was measured by an enzymatic cycling
method as described (14). Protein synthesis was measured by
[
 
3
 
H]leucine incorporation as described (11).
 
Caspase-3–like Protease Activity.
 
Cytosolic extracts of liver tis-
sue were prepared by Dounce homogenization of 
 
z
 
100 mg fro-
zen liver sample in hypotonic extraction buffer (25 mM Hepes,
pH 7.5, 5 mM MgCl
 
2
 
, 1 mM EGTA, 1 mM PEFA block, and 1
 
m
 
g/ml each of pepstatin, leupeptin, and aprotinin) and subse-
quently centrifuged (15 min, 13,000 
 
g
 
, 4
 
8
 
C). In cell culture ex-
periments, cells were washed three times with PBS and lysed with
hypotonic extraction buffer plus 0.1% Triton X-100. After cen-
trifugation (15 min, 13,000 
 
g
 
, 4
 
8
 
C) of the lysates, supernatants
were immediately frozen at 
 
2
 
80
 
8
 
C.
Generation of free 7-amino-4-trifluoromethylcoumarin (afc)
was followed in assay buffer (50 mM Hepes, pH 7.4, 1% sucrose,
0.1% CHAPS, 10 mM dithiothreitol, 50 
 
m
 
M fluorogenic sub-
strate 
 
N
 
-acetyl-asp-glu-val-asp-afc [DEVDafc; Biomol]) for 30
min at 37
 
8
 
C using a fluorometer plate reader VICTOR
 
2
 
 (Wallac
Instruments) set at an excitation wavelength of 385 nm and an
emission wavelength of 505 nm. Protein concentrations of corre-
sponding samples were quantitated with the Pierce Assay (Pierce
Chemical Co.), and the specific caspase-3–like protease activity
was calculated in picomoles of free afc per minute (
 
m
 
U) and mil-
ligram of protein using serially diluted standards (0–5 
 
m
 
M afc).
Control experiments confirmed that the activity was linear with
time and with protein concentration under the conditions de-
scribed above.
 
Western Blot Analysis.
 
The release of cytochrome c from
hepatocyte mitochondria was analyzed using a selective digitonin
permeabilization method, avoiding artifacts that might be gener-
ated by mechanical breakage of the outer mitochondrial mem-
brane of apoptotic cells by Dounce homogenization (37). At the
indicated time points, the culture medium of 6-well plates was
exchanged for permeabilization buffer (210 mM 
 
d
 
-mannitol, 70
mM sucrose, 10 mM Hepes, 5 mM succinate, 0.2 mM EGTA,
0.15% BSA, 50 
 
m
 
g/ml digitonin, and pH 7.2, 4°C) as described
(37). Cell culture plates were shaken gently for 5 min at 4
 
8
 
C,
then the permeabilization buffer was removed and centrifuged for
10 min at 13,000 
 
g
 
. Protein from the supernatants was separated
on 15% polyacrylamide gels. Cytochrome c was detected by the
enhanced chemiluminescence reaction after blotting on nitrocel-
lulose membranes with an mAb raised against pigeon cytochrome
 
c (clone 7H8.2C12; BD PharMingen). Bid was detected with an
anti–murine Bid antibody provided by Dr. B. Antonsson (Serono
Pharmaceutical Research Institute, Geneva, Switzerland) (38).
Phosphorylated I-
 
k
 
B was analyzed with a commercial antibody
(PhosphoPlus
 
®
 
 I-
 
k
 
B [Ser32] Antibody kit) from New England
Biolabs.
 
Fluorescence Microscopy.
 
Chromatin condensation was followed
on a fluorescence microscope (Leica DM-IRB equipped with a
40
 
3
 
, NA 0.5 long distance lens) in live cells after staining with
1 
 
m
 
g/ml H-33342 as described (16), or in fixed cells after staining
with 0.5 
 
m
 
g/ml H-33342. Mitochondrial membrane potential
was analyzed after staining with 20 ng/ml tetramethylrhodamine
ethyl ester (TMRE; Molecular Probes) (20). Cytochrome c im-
munocytochemistry was performed essentially as described (20,
37) in cells grown on collagen-coated glass coverslips and fixed
with paraformaldehyde (2%). In brief, hepatocytes were incu-
bated first with an anticytochrome c mAb (BD PharMingen) and
then with an Alexa 488–coupled secondary antibody plus H-33342,
before they were imaged on a confocal microscope (Leica TCS
4D equipped with a 63
 
3
 
, NA 1.3 lens).
 
Statistical Analysis.
 
Statistical differences were determined
with an unpaired 
 
t
 
 test if applicable, or data were analyzed by
one-way analysis of variance (ANOVA) followed by Dunnett’s
multiple comparison test. In the case of inhomogenous variances,
data were transformed before subjection to further analysis.
 
Results
 
ATP Depletion in Murine Hepatocytes by Fructose.
 
The
kinetics and the extent of ATP depletion by fructose were
tested in primary murine hepatocyte cultures. High con-
centrations of the sugar (50 mM) depleted ATP by 70–80%
within 5 min, and subsequently cellular steady state ATP
levels remained at 15–20% of control for at least 20 h (Fig.
1 A). At lower fructose concentrations (6–25 mM), the de-
pletion was less pronounced (40–70%) and reversible
within 5–10 h (Fig. 1 A). The median effective concentra-
tion (EC)
 
50
 
 of fructose for ATP depletion was 7.5 mM
(Fig. 1 B), and the sugar alone had no effect on basal hepa-
tocyte viability at any concentration tested (Fig. 1 C).
Hepatic ATP depletion by fructose is due to the prefer-
ential metabolism of this sugar via the aldolase pathway (26,
39, 40). In accordance, pronounced ATP depletion (75–
85%) was also observed after addition of a panel of other
carbohydrates metabolized via the aldolase pathway, such as
tagatose, sorbitol, and 2,5-anhydro-mannitol (all 50 mM),
whereas no ATP depletion was observed after addition of
50 mM glucose, sorbose, mannitol, or mannose (Fig. 2),
which are hardly metabolized via the aldolase pathway.
 
Prevention of TNF-induced Hepatocyte Apoptosis by ATP-
depleting Carbohydrates.
 
In ActD-sensitized murine hepato-
cytes, TNF induces classical apoptosis that can be easily
quantified by measuring the LDH release from dying cells
at late time points (4, 11). Fructose (50 mM) inhibited
TNF-induced cell death by 
 
.
 
95% (Fig. 1 C), and this pre-
vention was paralleled by a block of oligonucleosomal
DNA fragmentation (Fig. 1 D). All ATP-depleting carbo-
hydrates inhibited apoptosis, whereas the nondepleting
sugars had no such effect (Fig. 2). Notably, the potency of 
1978
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different sugars with regard to ATP depletion correlated
with the concentration dependence of their apoptosis inhi-
bition (Fig. 1, B and C). Experiments with eight different
carbohydrates showed that TNF-induced cell death was
not significantly affected when ATP was maintained above
a threshold level of 
 
z
 
40–50% of control. Complete inhibi-
tion was observed at ATP levels of 15–20% (Fig. 2).
The correlation of ATP depletion and protection from
TNF was further explored by examining the effect of ATP
repletion. Supplementation of the culture medium with
additional phosphate alleviated ATP depletion by the phos-
phate-trapping sugar, fructose, and restored ATP levels
above the critical threshold of 50% (Fig. 1 A). Restoration
of ATP levels correlated with a regain of sensitivity towards
TNF-induced apoptosis despite the continued presence of
fructose (Fig. 3).
ATP depletion by fructose also correlated with the inhi-
bition of TNF-induced apoptosis in other cell types. For
instance, in human HepG2 and murine Hepa1-6 hepatoma
cells, fructose did not significantly deplete ATP at concen-
trations of up to 50 mM, and consequently TNF-induced
apoptosis was not affected (change 
 
,
 
5%). Similarly, fruc-
tose had no effect on TNF-induced apoptosis in murine fi-
brosarcoma cells (WEHI-164) lacking the aldolase path-
way. In contrast, TNF-induced cell death was inhibited by
fructose in primary rat hepatocyte cultures (with active al-
dolase pathway) just as described for primary murine liver
cells (not shown).
 
Prevention of TNF-induced Caspase Activation and Cytochrome
c Release by Fructose.
 
Inhibition of caspases by peptide in-
hibitors correlates with the prevention of TNF-induced he-
patic apoptosis (8, 9). Therefore, we investigated whether
these proteases were inhibited by addition of fructose or
other carbohydrates. The reduction of type II caspase activ-
ity (DEVDafc cleavage) correlated closely with the inhibi-
Figure 1. Depletion of hepa-
tocyte ATP by different carbo-
hydrates and protection against
TNF-induced cell death. (A)
Primary murine hepatocyte cul-
tures were incubated with vari-
ous concentrations of fructose
(j, 50 mM; d, 12.5 mM; h, 6
mM; s, control [con]). Cellular
ATP content was quantified at
the time points indicated. In
some experiments, phosphate
(20 mM) was added to the cul-
tures 2 h before the addition of
12.5 mM fructose (m). ATP
content in untreated cells (30
nmol/106 cells) was set as 100%.
(B) ATP content in primary cells
was quantified 2 h after incuba-
tion with various concentrations
of fructose or tagatose. (C)
Hepatocytes were preincubated
for 15 min with various concen-
trations of fructose or tagatose,
then incubated with ActD (400
ng/ml) and 15 min later with
TNF (100 ng/ml). LDH release
was determined after 18 h. All
data are means 6 SD from three
experiments. (D) After 8 h,
DNA fragmentation was ana-
lyzed on a 1% agarose gel. The
lanes were loaded with samples
from the following incubations:
(1) control; (2) ActD (400 ng/
ml); (3) TNF (100 ng/ml); (4)
ActD/TNF; (5) fructose (50
mM)  1 ActD/TNF; and (6)
tagatose (50 mM) 1 ActD/TNF.
Figure 2. Correlation between ATP depletion and prevention of
TNF-induced cell death by different carbohydrates. Murine hepatocytes
were preincubated with carbohydrates in various concentrations (50, 25,
12, 6, 3, and 1.5 mM) and with ActD (400 ng/ml) for 30 min. Then, 100
ng/ml TNF was added, and specific cytotoxicity was assessed 18 h later
by determination of LDH release. In parallel experiments, hepatocytes
were lysed after incubation with carbohydrates for 2 h, and the ATP con-
tent was quantified. The correlation between LDH release and ATP con-
tent is shown. Filled symbols represent ATP-depleting carbohydrates, and
open symbols represent other carbohydrates. Each data point represents
the mean of a triplicate determination. The arrow indicates the threshold
ATP concentration that is required for complete TNF-induced cell death
to occur. 0% specific cytotoxicity corresponds to 20 6 4% basal LDH re-
lease, and 100% corresponds to 72 6 5% absolute LDH release after stim-
ulation with ActD/TNF in the absence of carbohydrates.
Figure 3. ATP repletion through phosphate addition restores ActD/
TNF-mediated hepatocyte cell death. Hepatocytes were preincubated for
2 h with combinations of potassium phosphate (20 mM, black bars), fruc-
tose (Fruc, 12.5 mM) for 30 min, and ActD (400 ng/ml) for 15 min.
Then, 100 ng/ml TNF was added and cytotoxicity was assessed 20 h later
by determination of LDH release. Data are means 6 SD from three exper-
iments. *P , 0.01 compared with ActD/TNF/fructose-treated controls
based on ANOVA, followed by the Dunnett’s multiple comparison test.1979 Latta et al.
tion of apoptosis over a wide range of concentrations and
sugars (Fig. 4). For instance, the extent of inhibition was
.95% for 50 mM fructose or 12 mM tagatose.
Even when caspase activity is inhibited, TNF-exposed
cells may still have seriously damaged mitochondria and die
by delayed necrosis (41). Therefore, we examined cyto-
chrome c release into the cytosol as a parameter for mito-
chondrial damage. Immunocytochemical analysis showed
that cytochrome c was released into the cytosol and the nu-
clei z8 h after incubation of hepatocytes with TNF. At
this stage, chromatin was still noncondensed, but plasma
membrane blebs started to form (Fig. 5 A). Chromatin and
released cytochrome c were sequestered into apoptotic
bodies 2–6 h later. Fructose completely prevented all apop-
totic changes, including cytochrome c redistribution (Fig. 5
B). Similar data were obtained when the amount of cyto-
solic cytochrome c was determined by immunoblot: the
mitochondrial intermembrane protein accumulated in the
cytosol 6–9 h after stimulation with TNF. Accumulation of
cytosolic cytochrome c was blocked by fructose (Fig. 5 C)
or tagatose (not shown). Functional imaging of mitochon-
dria with the membrane potential–sensitive dye TMRE
yielded essentially similar results: mitochondrial potential
remained intact up to 20 h after incubation with ActD/
TNF and fructose, whereas it was entirely dissipated in the
absence of the sugar (not shown).
Enhanced CD95-mediated Apoptosis by Fructose. When
apoptosis was triggered by maximal stimulation of the alter-
native death receptor CD95 with aCD95, ATP depletion
with different carbohydrates had little effect (Fig. 6 A).
Also, CD95-mediated activation of type II caspases (1,200 6
200% of control) was not inhibited. When suboptimal con-
centrations of aCD95 were used, ATP-depleting sugars
even increased CD95-mediated apoptosis, whereas non–
ATP-depleting sugars did not affect CD95-mediated apop-
tosis (Fig. 6 A). These experiments show that neither death
receptor activation, caspase-8 processing, nor the activity of
type II caspases can be directly inhibited by the presence of
fructose or by ATP depletion.
Our hypothesis that death receptor signaling per se is not
affected by ATP depletion was further corroborated by ex-
periments where TNF was added before fructose (50 mM)
to avoid any effect of the carbohydrate on initial receptor
aggregation and signaling events. Protection by fructose
was 90, 75, 65, or 55% when it was added after TNF with
a delay of 1, 2, 3, or 4 h, respectively. Thus, ATP depletion
Figure 4. Inhibition of ActD/TNF-induced caspase activation by ATP-
depleting carbohydrates. Hepatocytes were stimulated with TNF (T, 100
ng/ml) 15 min after incubation with ActD (A, 400 ng/ml), and 30 min
after preincubation with various concentrations of fructose, tagatose, or
glucose. Caspase-3–like protease activity was measured by quantifica-
tions of DEVDafc cleavage after 12 h. All data are means 6 SD from
three experiments.
Figure 5. Prevention of TNF-induced cytochrome c release, mem-
brane blebbing, and apoptotic nuclear changes by fructose. (A) Hepato-
cytes were fixed at 0, 8, or 10 h after exposure to ActD (400 ng/ml)/
TNF (100 ng/ml). After staining for cytochrome c (Cyt-c) and DNA (H-
33342), cells were imaged by two-channel confocal microscopy. Chro-
matin and the corresponding cytochrome c pattern are shown in separate
panels for one representative cell per time point. Control hepatocytes
showed a typical binuclear phenotype, with cytochrome c immunoreac-
tivity only in mitochondrial structures. The punctuate pattern of cyto-
chrome c corresponded exactly to the stain of mitochondria with Mi-
toTracker Red (not shown). After 8 h, cells started to bleb, and
cytochrome c spread all over the cell. Note especially the penetration of
the nuclei and the concentration in the blebs. After 10 h, chromatin was
strongly marginated and formation of apoptotic bodies started. (B) Cyto-
chrome c (green) and chromatin (red) were imaged 14 h after addition of
ActD/TNF. Distribution of cytochrome c all over the blebbing hepato-
cytes was obvious (middle). The chromatin was broken apart to crescent
shaped condensed lumps that were packed into blebs and apoptotic bod-
ies. More than 70% of the cells were affected at this stage, and a single
representative hepatocyte is shown here. In contrast, hepatocytes exposed
to ActD/TNF in the presence of fructose (Fruc, 50 mM) neither released
cytochrome c nor displayed chromatin changes or membrane blebs. A
larger number of cells is shown to demonstrate the complete protection
by fructose. Bars, 15 mM. (C) Cytosolic extracts from hepatocytes treated
for 3–18 h with ActD/TNF in the presence or absence of fructose (Fruc,
50 mM) were analyzed by Western blot for cytochrome c content. Each
lane was loaded with extracts from 105 hepatocytes, and the 13-kD cyto-
chrome c bands are shown.1980 ATP and Hepatocyte Apoptosis
strongly inhibited apoptosis, also when receptor ligation
had already been initiated. Finally, we examined a rapid
signaling event triggered by TNF, e.g., I-kB phosphoryla-
tion, which leads to NF-kB activation (42). Immunoblot-
ting experiments showed that similar amounts of I-kB
were phosphorylated 5–30 min after TNF in the presence
or absence of 50 mM fructose (not shown). These findings
indicate that apoptosis signals via TNF-R1 and CD95 dif-
fer fundamentally: only TNF-triggered pathways involve
an ATP-sensitive step located upstream of type II caspase
activation and downstream of receptor activation.
Increased CD95-mediated Apoptosis despite Metabolic Inhibi-
tion. The observed enhancement of CD95-mediated tox-
icity by ATP depletion (Fig. 6 B) may be due to secondary
metabolic consequences of ATP loss, as all the phosphate-
trapping carbohydrates also inhibited protein synthesis in a
concentration-dependent manner (not shown) (26). In the
hepatocyte culture system used here, ATP depletion by 50
mM fructose caused a drop of protein synthesis by .90%
as quantitated by measurement of [3H]leucine incorporation.
Direct inhibition of protein synthesis had a similar effect
as ATP depletion: CD95 toxicity was synergistically en-
hanced by cycloheximide (CHX) (Fig. 6 B) or several
other translational inhibitors (not shown). Enhancement of
overall cell death by ATP depletion or CHX may have
been due to a conversion of CD95-mediated apoptosis into
unspecific necrotic cell lysis. However, activation of
caspases (not shown) and morphological examination after
staining of the chromatin indicated purely apoptotic cell
death. Moreover, cell death was entirely prevented under
all conditions by the caspase inhibitor zVADfmk (Fig. 6 B).
Taken together, these findings show that hepatocyte apop-
tosis per se requires neither adequate ATP levels nor intact
protein synthesis, provided that the caspase cascade is di-
rectly triggered, e.g., by CD95 ligation. Alternately, these
data indicate that TNF-R1 binding and ligation alone were
not sufficient to trigger the caspase cascade and apoptosis, as
TNF-mediated apoptosis had to bypass an additional step
that was blocked by ATP depletion (Figs. 1 and 4).
Prevention of TNF-induced Hepatic Apoptosis by ATP De-
pletion. Having established the basic experimental system
in primary hepatocyte cultures, we were interested in
whether fructose had a similar effect on TNF-induced he-
patic apoptosis in vivo. For this purpose, we used GalN-
pretreated mice, which are highly sensitive to the induction
of selective hepatic apoptosis by TNF (4, 12). In agreement
with previous studies (26), injection of fructose into mice
caused a dose-dependent ATP depletion in the liver (Fig. 7
A). This depletion was associated with a significant protec-
tion from TNF-induced liver damage, as assessed by mea-
surement of plasma transaminases (Fig. 7 B), hepatic caspase
activity (Fig. 7 C), hepatic DNA fragmentation (Fig. 7 D),
and histological examination (not shown). A pronounced
protection by fructose was also observed in survival experi-
ments with GalN-sensitized mice: all animals died 8–12 h
after injection of TNF (2 mg/kg, n 5 8), whereas fructose-
pretreated mice (10 g/kg, n 5 8) survived the observation
Figure 6. Exacerbation of CD95-mediated apoptosis by ATP-depleting
carbohydrates and inhibitors of protein biosynthesis. (A) Murine hepato-
cytes were preincubated with various carbohydrates (50 mM each) for 30
min. Then, aCD95 was added at the concentrations indicated. 18 h later,
cytotoxicity was assessed by determination of LDH release. (B) Cells were
additionally preincubated with zVADfmk (10 mM) and/or CHX for 30
min. The percentage of apoptotic cells was determined after 18 h. Data
are means 6 SD from three experiments.
Figure 7. Dose-dependent ATP depletion by ketohexoses and protec-
tion against GalN/TNF-induced liver injury in mice. (A) The ATP con-
tent of the liver was quantified 30 min after application of various doses
of fructose. (B) 15 min before application of GalN (700 mg/kg), mice
were pretreated with fructose. TNF (2 mg/kg) was injected intravenously
15 min after GalN.  Liver injury was quantified by measurement of
plasma alanine aminotransferase (ALT) after 8 h, (C) by determination of
type II caspase activity by DEVDafc cleavage after 6 h, or (D) by mea-
surement of DNA fragmentation after 6 h. Carbohydrates such as glucose
and mannitol had no significant effect. Values are means 6 SD from six
animals per group. *P , 0.05 and **P , 0.01 compared with conditions
represented by white bars based on ANOVA, followed by the Dunnett’s
multiple comparison test.1981 Latta et al.
period of 3 mo. At the highest dose of fructose, liver pro-
tection was virtually complete, whereas glucose or manni-
tol neither depleted ATP nor reduced liver damage.
Correlation of ATP Depletion and Apoptosis Sensitivity In
Vivo. Analysis of the kinetics of ATP depletion after a
bolus injection of fructose showed that ATP levels dropped
by 70% within 30 min, reached a minimum (20% of con-
trol) after 1 h, and had recovered after 4 h (Fig. 8 A). When
TNF was injected 1 h after fructose, maximal protection
correlated with the maximum of ATP depletion at that
time point. When TNF was injected after 2 or 4 h, protec-
tion was decreasing, in parallel with the recovering hepatic
ATP levels (Fig. 8 B). This time course suggests a direct
link between the block of apoptosis and the metabolic ef-
fects of fructose. The data also argue against induction of
nonspecific tolerance, e.g., due to endotoxin contamina-
tion of the sugar and release of the tolerizing cytokine IL-1
(3, 43).
Modulation of CD95- and LPS-mediated Apoptosis by ATP
Depletion. In a final set of experiments, we examined
whether the opposing effects of ATP depletion on TNF-
R1– or CD95-induced hepatocyte death would also hold
true in vivo, and which effect would be predominant after
stimulation of liver damage with LPS as inflammogen.
Mice were injected with increasing doses of anti-CD95
antibody alone or in combination with a strongly ATP-
depleting dose of fructose. Under any condition, fructose
enhanced CD95-mediated apoptotic liver damage (Fig. 9)
similarly to the in vitro experiments. In GalN-sensitized
mice injected with LPS, fructose prevented liver damage
very potently (Fig. 9). Thus, fructose protected in the more
complex GalN/LPS paradigm of hepatic inflammation to a
similar extent as in the GalN/TNF apoptosis model.
Discussion
This study demonstrates that TNF-induced hepatocyto-
toxicity is prevented in vivo and in vitro after treatment
with fructose. This unexpected antiapoptotic action of the
sugar was exceptionally potent, as fructose completely
abolished liver damage of mice even after exposure to oth-
erwise lethal TNF doses. A similar robustness of fructose-
mediated protection was also seen in vitro, because hepato-
cyte apoptosis was reduced by .95% over a wide range of
different TNF concentrations. The effect of the sugar was
exquisitely specific for nontransformed hepatocytes, which
is not the case for caspase inhibitors of similar potency (8,
9). Fructose neither depleted ATP nor did it protect from
apoptosis in hepatoma cells (not shown), primary neurons
(23), and lymphoid cells (16). Thus, the cell type–selective
effects of the sugar may be used to differentially modulate
responses of tumor cells and hepatic parenchymal cells in
vivo.
A straightforward interpretation of our results is that
ATP depletion is the primary metabolic effect of fructose
responsible for prevention of TNF- or LPS-induced apop-
tosis. For instance, the degree of ATP depletion by a large
variety of sugars correlated with their inhibition of TNF-
triggered apoptosis and with the enhancement of CD95-
mediated cytotoxicity. In addition, the time course of ATP
depletion in hepatocyte cultures or in murine livers, re-
spectively, correlated with refractoriness to TNF-induced
apoptosis. The strongest support for the hypothesis that
ATP depletion by fructose is the primary metabolic cause
for the selective protection of hepatocytes from apoptosis
Figure 8. Kinetics of ATP depletion in murine livers by fructose and
correlation with protection against GalN/TNF-induced liver injury. (A)
The ATP content of murine liver homogenates was monitored at differ-
ent time points after injection of fructose (10 g/kg). (B) Mice were
treated with GalN/TNF as described, and liver injury was quantified by
measurement of plasma ALT after 8 h. Alternatively, mice were pre-
treated with fructose (10 g/kg) at different times before challenge with
TNF. Values are means 6 SD from six animals per group. *P , 0.05 and
**P  ,  0.01 compared with GalN/TNF-treated controls based on
ANOVA, followed by the Dunnett’s multiple comparison test.
Figure 9. Modulation of CD95- and GalN/LPS-mediated liver injury
by fructose. Mice were pretreated with fructose (2 g/kg) and 15 min later,
different doses of aCD95 were injected. Alternatively, mice were chal-
lenged with LPS (10 mg/kg) 15 min after GalN (700 mg/kg) pretreat-
ment. 8 h later, liver injury was quantified by measurement of plasma
ALT. Values are means 6 SD from three animals per group.1982 ATP and Hepatocyte Apoptosis
comes from ATP repletion experiments. For this line of ar-
gument, it is essential to rationalize the mechanism of ATP
depletion by fructose. Unlike most other commonly used
ATP depleters, fructose neither blocks ATP synthesis nor
depletes organic substrates for glycolysis or mitochondrial
energy generation. Rather, fructose is itself a substrate for
glycolysis that is phosphorylated so rapidly that it acts as a
sink for the cellular phosphate pool (39, 44). Cells survive
well under such conditions, as ATP is still slowly produced
by oxidative phosphorylation or glycolysis (33, 45). This
situation differs from ATP depletion with oligomycine or
rotenone, which is lethal to hepatocytes (46) unless they
are cultured in the additional presence of the alternative
metabolic substrates glycine (31) or fructose (33). The par-
ticular biochemical mechanism of ATP depletion by fruc-
tose explains the fact that ATP could not be repleted by
addition of any combination of the energy substrates glu-
cose, glutamate, alanine, glycerol, pyruvate, or lactate (this
study). However, supplementation of inorganic phosphate
to balance the amount trapped by fructose raised the cellu-
lar ATP content. Most importantly, this reconstituted ATP
pool made cells sensitive again to TNF, even in the pres-
ence of fructose. This strongly supports our view that fruc-
tose blocks hepatocyte apoptosis by ATP depletion.
Two further reasons other than lack of ATP as a possible
cause for the prevention of cell death after fructose are con-
sidered to be unlikely. First, intracellular acidification may
result from enhanced glycolysis, and has in fact been dem-
onstrated to protect, e.g., against ischemic hepatocyte ne-
crosis (30, 47–49). However, a decrease in pH increases ap-
optotic death of hepatocytes (40). In addition, we found no
pH dependence in vitro of TNF-induced apoptosis be-
tween pH 6.0 and 7.6 using various organic buffers (data
not shown). Second, an antioxidant function as claimed for
fructose (50) is unlikely to account for its prevention of ap-
optosis, as TNF-induced murine hepatocyte apoptosis is
not affected by antioxidants, glutathione precursors, or
chelation of iron (11, 12, 14), nor by the strongly antioxi-
dant carbohydrate mannitol (this study).
Modulation of apoptosis and ATP depletion were char-
acterized by a threshold ATP value of 40–50% of control.
From this threshold on, any further decrease of cellular
ATP was directly proportional to the reduction of TNF-
induced apoptosis over a wide range of concentrations with
various sugars. A quantitatively and qualitatively similar
correlation of ATP with apoptosis susceptibility has been
defined earlier in neuronal cultures and lymphoid cells after
inhibition of ATP synthesis with oligomycine or nitric ox-
ide (16, 20, 23). Thus, our study suggests the existence of a
general threshold level of intracellular ATP required for
progression of apoptosis. Notably, absolute ATP concen-
trations in hepatocytes are in the range of 3–5 mM (39).
Thus, the residual intracellular ATP levels under depletion
conditions (i.e., z20% of control) that blocked apoptosis
were still in the millimolar range and therefore several or-
ders of magnitude above those required for most kinases to
function.
The question arises as to the site of interference of fruc-
tose-induced ATP depletion with the apoptotic program.
To date, only one of the ATP-dependent apoptosis signal-
ing steps has been molecularly defined: hydrolysis of
deoxy-ATP or millimolar concentrations of ATP are re-
quired for conformational changes of apoptotic protease-
activating factor 1 (Apaf1) that are essential for formation of
the apoptosome (51). Apoptosome formation is generally
considered to occur downstream of mitochondrial cyto-
chrome c release. However, there is clear evidence from
various experimental systems, including hepatocytes, that
the apoptotic cascade may involve feedback loops of down-
stream effectors (caspase-3) acting back on the activation of
molecules that have been considered to be positioned apical
in the sequence of death signals (caspase-8, Bid, mitochon-
drial integrity) (52, 53). The question on whether the apop-
tosome is involved at all in death receptor–mediated hepa-
tocyte apoptosis would therefore be ideally studied in apaf-
12/2 or caspase-92/2 mice. However, such an approach
with knockout hepatocytes is prevented by the embryonal
lethality of the homozygote gene-targeted mice. The possi-
bility that ATP depletion may delay or halt the apoptotic
cascade at a step upstream of cytochrome c release and apop-
tosome formation (21–23, 54) is suggested by in vitro ex-
periments. Our study provides the evidence that such up-
stream mechanisms are in fact most relevant for apoptosis
block by ATP depletion in vivo. Apart from a differential
requirement for apoptosome formation, three theoretical
explanations remain for the different signaling of the two
death receptors, TNF-R1 and CD95. First, Bid or relatives
that link death receptors to mitochondria could play a role
in TNF-mediated apoptosis only. The finding that Bid-
deficient mice are resistant to CD95-induced hepatocellular
apoptosis argues against such a rationale (55). Analysis of
Bid involvement is complicated by the fact that this mole-
cule may release cytochrome c without being cleaved by
caspases (56). In agreement with this, we did not detect any
Bid cleavage in our hepatocyte cultures (data not shown).
Second, two different types of death receptor–mediated ap-
optosis signaling have been distinguished on the basis of
their different susceptibility to inhibition by Bcl-2: a direct
protease cascade (type 1), and a protease cascade controlled
by a Bcl-2–inhibitable mitochondrial amplification loop
(type 2) (57). As protection of hepatocytes by Bcl-2 from
CD95- or TNF-R1–mediated apoptosis has been observed
(13, 58, 59), a direct protease cascade triggered by either
death receptor seems unlikely in hepatocytes. Third, the
fact that both TNF-R1 and CD95 require Fas-associated
death domain protein for signal transduction does not ex-
clude that different signaling pathways may be initiated
from the two different death-inducing signaling complexes
(42). TNF-R1–mediated apoptosis may require two oblig-
atory signal cascades. One of these comprises the caspase
cascade common also to CD95 and thus sensitive to caspase
inhibitors. The second signal, possibly triggered only by
TNF, may require ATP. Two examples may illustrate the
possibility of a second signal in TNF-R1 signaling: the ne-
cessity of receptor internalization (60), and a caspase-8–
independent death pathway that triggers necrosis in L-9291983 Latta et al.
cells independent of the caspase cascade (61).
The most proximal receptor-mediated events are un-
likely to be affected by fructose for the following reasons:
TNF-R1 has been shown to be solely responsible for apop-
tosis induction by TNF in hepatocytes (4). After ligand
binding, this receptor trimerizes and adapter protein re-
cruitment to the receptor initiates different signaling path-
ways (42). The most prominent ones are activation of the
transcription factor nuclear factor (NF)-kB and activation
of apoptosis by processing of caspase-8 (42, 51). Our find-
ing that the NF-kB pathway is also activated in the pres-
ence of fructose suggests that receptor aggregation and re-
cruitment of some signaling adapter molecules are not
defective in ATP-depleted cells. This is further corrobo-
rated by our finding that CD95-mediated apoptosis in
hepatocytes is not blocked by ATP depletion. As CD95-
mediated apoptosis involves similar initial activation mech-
anisms for caspase-8 as those triggered via TNF-R1 (42), it
is likely that this initial step of cell death signaling was not
inhibited by ketohexoses.
Typical steps of the apoptotic cascade that can be posi-
tioned clearly downstream of the step blocked by ATP
depletion are the activation of type II caspases and the
release of cytochrome c from mitochondria. The full activ-
ity of CD95-triggered type II caspases in the presence of
fructose showed further that it is not the enzymatic activ-
ity of caspases themselves that is blocked by ATP deple-
tion or fructose, but rather a step leading to their activation
by TNF.
Our data provide clear evidence that cell death signaling
in hepatocytes by TNF-R1 and CD95 can be differentially
regulated. Why is this possible when both death receptors
use similar initial signaling pathways? Inhibition of protein
synthesis by the metabolic effects of fructose (26) may con-
tribute to the enhancement of CD95-mediated death and
protection from TNF. In fact, the general protein synthesis
inhibitor CHX has also been shown to enhance CD95 tox-
icity to hepatocytes (Fig. 6) and to reduce TNF toxicity
(11). Fructose has been shown to inhibit protein synthesis
selectively in the liver by ATP depletion (26), and we also
found in this study that fructose arrests protein synthesis in
parallel with its depleting effect on cellular ATP. However,
mechanisms triggered by the initial ATP depletion other
than translational arrest could also be relevant, as the pro-
tection by fructose was consistently more pronounced and
robust than the protection we observed (3, 5, 11) with
CHX or other inhibitors of protein synthesis. Differences
between CD95 and TNF have also been observed in other
systems. CD95 cross-linking triggers a proteolytic cascade
that in some cells is sufficient alone to execute apoptosis
(51, 57). In such a direct chain of proteolytic events, ATP
depletion may not have any inhibitory effect. The majority
of other known apoptotic signals, including TNF-R1 stim-
ulation, requires enhancing loops and parallel pathways for
the full-blown activation of type II caspases and cell death
(41, 51, 57). We show here that one of the key regulatory
steps in the TNF pathway requires high (.50% of control)
ATP levels. Thus, modulation of cellular ATP levels ap-
pears to represent a cellular master switch for TNF-induced
hepatocyte apoptosis with a similar potency as Bcl-2 in
many other apoptotic model systems.
Our study shows that the decision of a hepatocyte to
undergo apoptosis in vivo is controlled by basic metabolic
parameters in addition to the well-known interactions of
specific signaling molecules. For instance, an adequate glu-
tathione status is required in murine livers for TNF- and
CD95-mediated apoptosis to occur (14, 15), and excessive
reactive oxygen or nitric oxide stress frequently prevents
apoptosis signaling (62). We demonstrate here that the cel-
lular ATP level can be an additional key switch controlling
apoptosis and organ failure in vivo. Exploitation of this re-
fined knowledge base will facilitate the development of im-
proved strategies for chemotherapy, pharmacological inter-
ventions, or control of liver failure. In addition, this
metabolic control provides an explanation for apoptosis
prevention and the occurrence of relatively widespread ne-
crosis (2, 63) in pathological liver failure, where frequently
ATP and glutathione are depleted and irreversibly damaged
hepatocytes have to die eventually by necrosis.
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